CHEK2 and lung carcinoma: Small molecule inhibitors of ATM or its downstream target Chk2 cooperate with Chk1 inhibitors to specifically inhibit growth of cultured lung cancer cells or xenograft tumors with Onc-p53 inducing apoptosis.